Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 2042, is shown as follows: Dec. 31, 2013 Dec. 31, 20Y2 Assets Cash $303,170 $282,020 Accounts receivable (net) 109,830 101,290 Inventories 310,040 299,900 Investments 116,190 Land 159,020 0 342,070 265,140 Equipment Accumulated depreciation-equipment (80,080) (71,500) Total assets $1,144,050 $993,040 $207,070 $195,630 20,590 25,820 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) Accrued expenses payable (operating expenses) Dividends payable Common stock, $10 par Paid-in capital: Excess of issue price over par-common stock Retained earnings 11,440 8,940 61,780 48,660 232,240 135,050 610,930 578,940 Total liabilities and stockholders' equity $1,144,050 $993,040 Additional data obtained from an examination of the accounts in the ledger for 2013 are as follows: a. The investments were sold for $135,940 cash. b. Equipment and land were acquired for cash. C. There were no disposals of equipment during the year. d. The common stock was issued for cash. e. There was a $78,660 credit to Retained Earnings for net income. f. There was a $46,670 debit to Retained Earnings for cash dividends declared. Required: Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments. Livers Inc. Statement of Cash Flows For the Year Ended December 31, 20Y3 Cash flows from operating activities: Adjustments to reconcile net income to net cash flow from operating activities: Changes in current operating assets and liabilities: Net cash flow from operating activities Cash flows from investing activities: Il bill bol 10 1000 Net cash flow used for investing activities Cash flows from financing activities: Net cash flow from financing activities Cash at the beginning of the year Cash at the end of the year